The Trial of Pessary After Laser for TTTS (PECEPLASER)
Arabin Cervical Pessary for Prevention of Preterm Birth in Cases of Twin-to-twin Transfusion Syndrome Treated by Fetoscopic Laser Coagulation: The PECEP Laser Trial
Sponsor: Bürgerhospital Frankfurt
Terminated
Interim analysis unfavorable to continue the study
Listed as NCT01334489, this NA trial focuses on Premature Birth and remains terminated or withdrawn. Sponsored by Bürgerhospital Frankfurt, it has been updated 9 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Nov 2022 — Jul 2024 [monthly]
Terminated NA
-
Jan 2021 — Nov 2022 [monthly]
Terminated NA
-
Sep 2020 — Jan 2021 [monthly]
Terminated NA
Status: Unknown Status → Terminated
▶ Show 4 earlier versions
-
Apr 2019 — Sep 2020 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jun 2018 — Apr 2019 [monthly]
Recruiting NA
-
Apr 2017 — Jun 2018 [monthly]
Recruiting NA
Phase: PHASE4 → NA
-
Jan 2017 — Apr 2017 [monthly]
Recruiting PHASE4
First recorded
Dec 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bürgerhospital Frankfurt
- Hospital Universitari Vall d'Hebron Research Institute
- Maternal-Infantil Vall d´Hebron Hospital
- Universitaire Ziekenhuizen KU Leuven
- Universitätsklinikum Hamburg-Eppendorf
For direct contact, visit the study record on ClinicalTrials.gov .